UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The effects of patient out‐of‐pocket costs on insulin use among people with type 1 and type 2 diabetes with Medicare Advantage insurance—2014–2018

Health services research, 2024-02, Vol.59 (1), p.e14152-n/a

2024

Volltextzugriff (PDF)

Comparative effectiveness of once‐weekly glucagon‐like peptide‐1 receptor agonists with regard to 6‐month glycaemic control and weight outcomes in patients with type 2 diabetes

Diabetes, obesity & metabolism, 2018-02, Vol.20 (2), p.468-473

2018

Volltextzugriff (PDF)

Impact of Self-Monitoring of Blood Pressure on Processes of Hypertension Care and Long-Term Blood Pressure Control

Journal of the American Heart Association, 2020-08, Vol.9 (15), p.e016174-e016174

2020

Volltextzugriff (PDF)

Estimated Yield of Screening for Heterozygous Familial Hypercholesterolemia With and Without Genetic Testing in US Adults

Journal of the American Heart Association, 2022-06, Vol.11 (11), p.e025192-e025192

2022

Volltextzugriff (PDF)

Cost-Effectiveness of Treatment Options for Neuropathic Pain: a Systematic Review

PharmacoEconomics, 2019-05, Vol.37 (5), p.669-688

2019

Volltextzugriff (PDF)

Clinic-Based Strategies to Reach United States Million Hearts 2022 Blood Pressure Control Goals: A Simulation Study

Circulation Cardiovascular quality and outcomes, 2019-06, Vol.12 (6), p.e005624-e005624

2019

Volltextzugriff (PDF)

Cost-Effectiveness of Hypertension Treatment by Pharmacists in Black Barbershops

Circulation (New York, N.Y.), 2021-06, Vol.143 (24), p.2384-2394

2021

Volltextzugriff (PDF)

Cost of Cardiovascular Disease Event and Cardiovascular Disease Treatment-Related Complication Hospitalizations in the United States

Circulation Cardiovascular quality and outcomes, 2024-03, Vol.17 (3), p.e009999

2024

Volltextzugriff (PDF)

Factors Associated with Diabetes-Related Clinical Inertia in a Managed Care Population and Its Effect on Hemoglobin A1c Goal Attainment: A Claims-Based Analysis

Journal of managed care & specialty pharmacy, 2019-03, Vol.25 (3), p.304-313

2019

Volltextzugriff (PDF)

Estimated Population Health Benefits of Intensive Systolic Blood Pressure Treatment Among SPRINT-Eligible US Adults

American journal of hypertension, 2023-08, Vol.36 (9), p.498-508

2023

Volltextzugriff (PDF)

A RESPONSE TO: "COST-EFFECTIVENESS OF ORAL SEMAGLUTIDE ADDED TO CURRENT ANTIHYPERGLYCEMIC TREATMENT FOR TYPE 2 DIABETES"

Journal of managed care & specialty pharmacy, 2021-08, Vol.27 (8), p.1140-1141

2021

Volltextzugriff (PDF)

1101-P: Association between Insulin Utilization and Average Out-of-Pocket Cost in Commercially Insured Patients with Diabetes

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Volltextzugriff (PDF)

1102-P: Association between Insulin Utilization and Average Out-of-Pocket Cost in Medicare Advantage Patients with Diabetes

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Volltextzugriff (PDF)

Cost-effectiveness of technetium pyrophosphate scintigraphy versus heart biopsy for the diagnosis of transthyretin amyloidosis

Amyloid, 2019-03, Vol.26 (sup1), p.71-72

2019

Volltextzugriff (PDF)

The effects of patient out-of-pocket costs for insulin on medication adherence and health care utilization in patients with commercial insurance; 2007-2018

Journal of managed care & specialty pharmacy, 2022-05, Vol.28 (5), p.494-506

2022

Volltextzugriff (PDF)

Abstract 02: Distribution Of Predicted Cardiovascular And All-cause Mortality Benefit Of Intensive Vs Standard Blood Pressure Control Among Us Adults Eligible For The Systolic Blood Pressure Intervention Trial

Hypertension (Dallas, Tex. 1979), 2021-09, Vol.78 (Suppl_1)

2021

Volltextzugriff (PDF)

Cost-Effectiveness of Intensive versus Standard Blood-Pressure Control

The New England journal of medicine, 2017-08, Vol.377 (8), p.745-755

2017

Volltextzugriff (PDF)

Abstract P176: Impact of Serious Adverse Event Risks on the Cost-effectiveness of Intensive Blood Pressure Goals in Patients Aged ≥75 Years

Circulation (New York, N.Y.), 2017-03, Vol.135 (suppl_1)

2017

Volltextzugriff (PDF)

Using Electronic Medical Records to Assess the Effectiveness of Pharmacotherapy in Pain: A Review of Recent Observational Studies

Journal of pain & palliative care pharmacotherapy, 2016-07, Vol.30 (3), p.210-217

2016

Volltextzugriff (PDF)

Abstract 096: Comparing Strategies to Improve Systolic Blood Pressure Over 10 Years: A Simulation Study Using the Blood Pressure Control Model

Hypertension (Dallas, Tex. 1979), 2017-09, Vol.70 (suppl_1)

2017

Volltextzugriff (PDF)

The effects of patient out-of-pocket costs for insulin on medication adherence and health care utilization in patients with commercial insurance; 2007-2018

Journal of managed care & specialty pharmacy, 2022-05, Vol.28 (5), p.494

2022

Volltextzugriff (PDF)

COST-EFFECTIVENESS OF INTENSIVE BLOOD PRESSURE GOALS IN PATIENTS WITH PRIOR CARDIOVASCULAR DISEASE

Journal of the American College of Cardiology, 2017-03, Vol.69 (11), p.1683-1683

2017

Volltextzugriff (PDF)

Abstract P178: Cost-Effectiveness of Intensive versus Standard Blood Pressure Goals by Baseline Systolic Blood Pressure Levels in SPRINT-Eligible US Adults

Circulation (New York, N.Y.), 2017-03, Vol.135 (suppl_1)

2017

Volltextzugriff (PDF)

Clinic-Based Strategies to Reach United States Million Hearts 2022 Blood Pressure Control Goals

Circulation Cardiovascular quality and outcomes, 2019-06, Vol.12 (6), p.e005624

2019

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieBlood

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

Humans
(15)
Life Sciences & Biomedicine
(13)
Science & Technology
(13)
Aged
(6)
Blood Pressure
(6)
Cardiovascular System & Cardiology
(6)
Adult
(5)
Cardiac & Cardiovascular Systems
(5)
Cardiovascular Disease
(5)
Diabetes
(5)
Diabetes Mellitus, Type 2 - Drug Therapy
(5)
Electronic Medical Records
(5)
Hypertension
(5)
Male
(5)
Middle Aged
(5)
Diabetes Mellitus
(4)
Female
(4)
Health Care Sciences & Services
(4)
Hypertension - Drug Therapy
(4)
Hypoglycemic Agents - Therapeutic Use
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The effects of patient out‐of‐pocket costs on insulin use among people with type 1 and type 2 diabetes with Medicare Advantage insurance—2014–2018

Comparative effectiveness of once‐weekly glucagon‐like peptide‐1 receptor agonists with regard to 6‐month glycaemic control and weight outcomes in patients with type 2 diabetes

Impact of Self-Monitoring of Blood Pressure on Processes of Hypertension Care and Long-Term Blood Pressure Control

Estimated Yield of Screening for Heterozygous Familial Hypercholesterolemia With and Without Genetic Testing in US Adults

Cost-Effectiveness of Treatment Options for Neuropathic Pain: a Systematic Review

Clinic-Based Strategies to Reach United States Million Hearts 2022 Blood Pressure Control Goals: A Simulation Study

Cost-Effectiveness of Hypertension Treatment by Pharmacists in Black Barbershops

Cost of Cardiovascular Disease Event and Cardiovascular Disease Treatment-Related Complication Hospitalizations in the United States

Factors Associated with Diabetes-Related Clinical Inertia in a Managed Care Population and Its Effect on Hemoglobin A1c Goal Attainment: A Claims-Based Analysis

Estimated Population Health Benefits of Intensive Systolic Blood Pressure Treatment Among SPRINT-Eligible US Adults

A RESPONSE TO: "COST-EFFECTIVENESS OF ORAL SEMAGLUTIDE ADDED TO CURRENT ANTIHYPERGLYCEMIC TREATMENT FOR TYPE 2 DIABETES"

1101-P: Association between Insulin Utilization and Average Out-of-Pocket Cost in Commercially Insured Patients with Diabetes

1102-P: Association between Insulin Utilization and Average Out-of-Pocket Cost in Medicare Advantage Patients with Diabetes

Cost-effectiveness of technetium pyrophosphate scintigraphy versus heart biopsy for the diagnosis of transthyretin amyloidosis

The effects of patient out-of-pocket costs for insulin on medication adherence and health care utilization in patients with commercial insurance; 2007-2018

Abstract 02: Distribution Of Predicted Cardiovascular And All-cause Mortality Benefit Of Intensive Vs Standard Blood Pressure Control Among Us Adults Eligible For The Systolic Blood Pressure Intervention Trial

Cost-Effectiveness of Intensive versus Standard Blood-Pressure Control

Abstract P176: Impact of Serious Adverse Event Risks on the Cost-effectiveness of Intensive Blood Pressure Goals in Patients Aged ≥75 Years

Using Electronic Medical Records to Assess the Effectiveness of Pharmacotherapy in Pain: A Review of Recent Observational Studies

Abstract 096: Comparing Strategies to Improve Systolic Blood Pressure Over 10 Years: A Simulation Study Using the Blood Pressure Control Model

The effects of patient out-of-pocket costs for insulin on medication adherence and health care utilization in patients with commercial insurance; 2007-2018

COST-EFFECTIVENESS OF INTENSIVE BLOOD PRESSURE GOALS IN PATIENTS WITH PRIOR CARDIOVASCULAR DISEASE

Abstract P178: Cost-Effectiveness of Intensive versus Standard Blood Pressure Goals by Baseline Systolic Blood Pressure Levels in SPRINT-Eligible US Adults

Clinic-Based Strategies to Reach United States Million Hearts 2022 Blood Pressure Control Goals

Aktive Filter

Suchergebnisse filtern